O
ALNY icon

OppenheimerFunds’s Alnylam Pharmaceuticals ALNY Stock Holding History

OppenheimerFunds’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-73,840
Closed -$5.93M – 1740
2015
Q3 		$5.93M Buy
73,840
+6,520
+10% +$724K 0.01% 801
2015
Q2 		$8.07M Buy
67,320
+5,150
+8% +$615K 0.01% 786
2015
Q1 		$6.49M Buy
62,170
+3,160
+5% +$320K 0.01% 816
2014
Q4 		$5.72M Buy
+59,010
New +$5.47M 0.01% 820
2014
Q3 		– Sell
-146,300
Closed -$9.24M – 911
2014
Q2 		$9.24M Buy
146,300
+170
+0.1% +$10.1K 0.01% 768
2014
Q1 		$9.81M Sell
146,130
-36,150
-20% -$2.8M 0.01% 757
2013
Q4 		$11.7M Buy
+182,280
New +$10.9M 0.01% 702

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return